Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Boston Scientific inks deal worth $14.5B | FDA clears opportunistic AI | TAVR’s next big challenge | Good news for OBLs & ASCs
Friday, January 16, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Boston Scientific to acquire Penumbra for $14.5B

This is a cash and stock transaction that values Penumbra at $374 per share. The move helps Boston Scientific expand its vascular and neurovascular portfolios, gaining new treatments for pulmonary embolism, stroke, deep vein thrombosis and many other critical cardiovascular conditions. 

READ MORE >
business handshake
Share on Twitter Share on Facebook Share on Linkedin

Boston Scientific to acquire Penumbra for $14.5B

Share on Twitter Share on Facebook Share on Linkedin
business handshake
This is a cash and stock transaction that values Penumbra at $374 per share. The move helps Boston Scientific expand its vascular and neurovascular portfolios, gaining new treatments for pulmonary embolism, stroke, deep vein thrombosis and many other critical cardiovascular conditions. 
READ MORE >

FDA clears opportunistic AI for detecting cardiothoracic issues in CT scans

“Coronary calcium revealed long ago that atherosclerosis begins well before symptoms. AI-CVD extends that insight by enabling systematic identification of patients who are unaware of their cardiovascular risk using CT scans that already exist,” said Arthur Agatston, MD.

READ MORE >
The U.S. Food and Drug Administration (FDA) has cleared HeartLung Corporation's AI-CVD, an artificial intelligence (AI) algorithm that looks at 11 different opportunistic health screening assessments on chest CT exams ordered for any reason.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears opportunistic AI for detecting cardiothoracic issues in CT scans

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) has cleared HeartLung Corporation's AI-CVD, an artificial intelligence (AI) algorithm that looks at 11 different opportunistic health screening assessments on chest CT exams ordered for any reason.
“Coronary calcium revealed long ago that atherosclerosis begins well before symptoms. AI-CVD extends that insight by enabling systematic identification of patients who are unaware of their cardiovascular risk using CT scans that already exist,” said Arthur Agatston, MD.
READ MORE >

TAVR’s next big challenge: Providing consistent relief for heart patients with aortic regurgitation

TAVR has already transformed care for patients with severe aortic stenosis. Will it make a similar impact on the treatment of aortic regurgitation?

READ MORE >
cardiologist patient heart compensation starting salary 2022 interventional cardiologist
Share on Twitter Share on Facebook Share on Linkedin

TAVR’s next big challenge: Providing consistent relief for heart patients with aortic regurgitation

Share on Twitter Share on Facebook Share on Linkedin
cardiologist patient heart compensation starting salary 2022 interventional cardiologist
TAVR has already transformed care for patients with severe aortic stenosis. Will it make a similar impact on the treatment of aortic regurgitation?
READ MORE >

Office-based interventional labs see boost in pay in 2026

CMS has made it a priority to increase payments for procedures performed by office-based labs and ambulatory surgical centers. This was reflected in policy changes made as part of the 2026 Medicare Physicians Fee Schedule.

READ MORE >
 Hospital patient bays recovery Banner Health and Atlas Ambulatory Surgical Center (ASC) in Sun City, Arizona.
Share on Twitter Share on Facebook Share on Linkedin

Office-based interventional labs see boost in pay in 2026

Share on Twitter Share on Facebook Share on Linkedin
 Hospital patient bays recovery Banner Health and Atlas Ambulatory Surgical Center (ASC) in Sun City, Arizona.
CMS has made it a priority to increase payments for procedures performed by office-based labs and ambulatory surgical centers. This was reflected in policy changes made as part of the 2026 Medicare Physicians Fee Schedule.
READ MORE >

Featured Articles

ASNC reports shortage of cardiac amyloidosis radiotracers

The two vendors involved say supplies of PYP and HDP could be disrupted for months.

READ MORE >
cardiac amyloidosis on bone scan. Image courtesy of the Department of Nuclear Medicine, Medical University of Vienna, Austria.
Share on Twitter Share on Facebook Share on Linkedin

ASNC reports shortage of cardiac amyloidosis radiotracers

Share on Twitter Share on Facebook Share on Linkedin
cardiac amyloidosis on bone scan. Image courtesy of the Department of Nuclear Medicine, Medical University of Vienna, Austria.
The two vendors involved say supplies of PYP and HDP could be disrupted for months.
READ MORE >

Low-volume operators linked to worse outcomes after TAVR, M-TEER

Researchers tracked data from more than 400,00 patients, sharing their findings in JAMA Cardiology.

READ MORE >
Cardiologist heart
Share on Twitter Share on Facebook Share on Linkedin

Low-volume operators linked to worse outcomes after TAVR, M-TEER

Share on Twitter Share on Facebook Share on Linkedin
Cardiologist heart
Researchers tracked data from more than 400,00 patients, sharing their findings in JAMA Cardiology.
READ MORE >

FDA clears MRI-compatible EP mapping catheter

This represents the first FDA clearance for Imricor Medical Systems. "It’s an exciting achievement and a date to be noted and remembered," CEO Steve Wedan said in a statement. 

READ MORE >
Vision-MR Diagnostic Catheter
Share on Twitter Share on Facebook Share on Linkedin

FDA clears MRI-compatible EP mapping catheter

Share on Twitter Share on Facebook Share on Linkedin
Vision-MR Diagnostic Catheter
This represents the first FDA clearance for Imricor Medical Systems. "It’s an exciting achievement and a date to be noted and remembered," CEO Steve Wedan said in a statement. 
READ MORE >

Rape charges against Texas cardiologist dropped as part of plea agreement

The traveling clinician pleaded guilty to three counts of second-degree assault. All other charges were dropped, and he was released from jail. According to his attorney, the cardiologist agreed to this plea agreement to "get on with his life." 

READ MORE >
judge court gavel justice system legal
Share on Twitter Share on Facebook Share on Linkedin

Rape charges against Texas cardiologist dropped as part of plea agreement

Share on Twitter Share on Facebook Share on Linkedin
judge court gavel justice system legal
The traveling clinician pleaded guilty to three counts of second-degree assault. All other charges were dropped, and he was released from jail. According to his attorney, the cardiologist agreed to this plea agreement to "get on with his life." 
READ MORE >

In Case You Missed It

Cardiology’s biggest trend: New scientific statements take on AI-powered coronary plaque evaluations

The ACC and AHA both issued new statements on noninvasive CCTA offerings that use advanced AI to evaluate patients with suspected CAD. These technologies have gained significant momentum in recent years, and experts agree that they represent a game-changing advancement in the world of cardiovascular imaging.

READ MORE >
HeartFlow Plaque Analysis. A European Heart Journal – Cardiovascular Imaging study compared the noninvasive Plaque Analysis technology developed by HeartFlow, which uses advanced AI algorithms to evaluate coronary CT angiography (CCTA) images, with coronary plaque assessments achieved by using intravascular ultrasound (IVUS). The REVEALPLAQUE trial included data from 237 patients. Plaque Analysis showed strong correlation and high accuracy when compared with IVUS.
Share on Twitter Share on Facebook Share on Linkedin

Cardiology’s biggest trend: New scientific statements take on AI-powered coronary plaque evaluations

Share on Twitter Share on Facebook Share on Linkedin
HeartFlow Plaque Analysis. A European Heart Journal – Cardiovascular Imaging study compared the noninvasive Plaque Analysis technology developed by HeartFlow, which uses advanced AI algorithms to evaluate coronary CT angiography (CCTA) images, with coronary plaque assessments achieved by using intravascular ultrasound (IVUS). The REVEALPLAQUE trial included data from 237 patients. Plaque Analysis showed strong correlation and high accuracy when compared with IVUS.
The ACC and AHA both issued new statements on noninvasive CCTA offerings that use advanced AI to evaluate patients with suspected CAD. These technologies have gained significant momentum in recent years, and experts agree that they represent a game-changing advancement in the world of cardiovascular imaging.
READ MORE >

SCAI town hall addresses workforce concerns in interventional cardiology

One of the event's primary takeaways was that interventional cardiology does still attract a healthy number of trainees. However, SCAI sees several ways the specialty can improve to be even more appealing in the future. 

READ MORE >
Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.
Share on Twitter Share on Facebook Share on Linkedin

SCAI town hall addresses workforce concerns in interventional cardiology

Share on Twitter Share on Facebook Share on Linkedin
Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.
One of the event's primary takeaways was that interventional cardiology does still attract a healthy number of trainees. However, SCAI sees several ways the specialty can improve to be even more appealing in the future. 
READ MORE >

Success in treating congenital heart disease prompted need for new adult guidelines

The American College of Cardiology and American Heart Association have issued new guidelines for the management of congenital heart disease in adults. The document outlines how to manage these patients, the challenges they face and much more.

READ MORE >
Cardiac echo ultrasound strain exam live scanning training class at ASE 2030.
Share on Twitter Share on Facebook Share on Linkedin

Success in treating congenital heart disease prompted need for new adult guidelines

Share on Twitter Share on Facebook Share on Linkedin
Cardiac echo ultrasound strain exam live scanning training class at ASE 2030.
The American College of Cardiology and American Heart Association have issued new guidelines for the management of congenital heart disease in adults. The document outlines how to manage these patients, the challenges they face and much more.
READ MORE >

In Other News

AI roundup: Of workslop and rework | Patent that tech, industry player | Artificial Intellectualism, anyone?

Across industries, more than a third of the time saved by AI gets eaten by overstretched humans who have to clean up the technology’s sloppy work. 

READ MORE >
AI workslop rework
Share on Twitter Share on Facebook Share on Linkedin

AI roundup: Of workslop and rework | Patent that tech, industry player | Artificial Intellectualism, anyone?

Share on Twitter Share on Facebook Share on Linkedin
AI workslop rework
Across industries, more than a third of the time saved by AI gets eaten by overstretched humans who have to clean up the technology’s sloppy work. 
READ MORE >

HHS reinstates hundreds of CDC workers fired by DOGE

The rehired workers were all part of the Centers for Disease Control and Prevention’s National Institute for Occupational Safety and Health (NIOSH). A union representing federal workers confirmed the reinstatements, and the Department of Health and Human Services has already sent emails to affected staff. 

READ MORE >
U.S. Department of Health and Human Services (HHS) sign.
Share on Twitter Share on Facebook Share on Linkedin

HHS reinstates hundreds of CDC workers fired by DOGE

Share on Twitter Share on Facebook Share on Linkedin
U.S. Department of Health and Human Services (HHS) sign.
The rehired workers were all part of the Centers for Disease Control and Prevention’s National Institute for Occupational Safety and Health (NIOSH). A union representing federal workers confirmed the reinstatements, and the Department of Health and Human Services has already sent emails to affected staff. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup